Cancer incidence according to the National Health Information Database in Korean patients with end-stage renal disease receiving hemodialysis
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to investigate incidence, survival, and risk factors of cancer in end-stage renal disease (ESRD) patients with hemodialysis using information from the National Health Information Database (NHID). Methods: Using the NHID, we identified ESRD patients who started maintenance hemodialysis between 2003 and 2005 in Korea. Patients were followed from initiation of hemodialysis to renal transplantation, death, or December 31, 2016, whichever came first. We calculated the incidence, survival, and risk factors of cancer. Results: Of the total 14,382 ESRD patients, 1,124 (7.82%; men:women, 728:396) were diagnosed with cancer during follow-up. The mean duration from the start of hemodialysis to new cancer identification was 64.40 ± 41.81 months. Significant risk factors for the development of new cancer were old age, male sex, and liver disease. Conversely, patients with diabetes showed low risk for new cancer. The colorectum (17.31%) was the most common primary site of cancer in men, followed by the liver (15.8%), stomach (14.29%), lung (13.6%), and kidney (10.3%). In women, the colorectum (14.65%) was also the most common primary site of cancer, followed by the breast (12.88%), thyroid (12.63%), stomach (10.86%), and lung (8.08%). According to the primary site of cancer, breast cancer showed the longest median survival duration (130.93 months), followed by thyroid, kidney, colorectum, bladder, stomach, liver, and lung cancer. On multivariate analyses, overall survival was affected by age and diabetes. Conclusions: The cancer incidence of chronic hemodialysis patients was relatively high. Thus, careful monitoring and a specific cancer screening program are needed for chronic hemodialysis patients.
Abstract
Background/Aims: The aim of this study was to investigate incidence, survival, and risk factors of cancer in end-stage renal disease (ESRD) patients with hemodialysis using information from the National Health Information Database (NHID). Methods: Using the NHID, we identified ESRD patients who started maintenance hemodialysis between 2003 and 2005 in Korea. Patients were followed from initiation of hemodialysis to renal transplantation, death, or December 31, 2016, whichever came first. We calculated the incidence, survival, and risk factors of cancer. Results: Of the total 14,382 ESRD patients, 1,124 (7.82%; men:women, 728:396) were diagnosed with cancer during follow-up. The mean duration from the start of hemodialysis to new cancer identification was 64.40 ± 41.81 months. Significant risk factors for the development of new cancer were old age, male sex, and liver disease. Conversely, patients with diabetes showed low risk for new cancer. The colorectum (17.31%) was the most common primary site of cancer in men, followed by the liver (15.8%), stomach (14.29%), lung (13.6%), and kidney (10.3%). In women, the colorectum (14.65%) was also the most common primary site of cancer, followed by the breast (12.88%), thyroid (12.63%), stomach (10.86%), and lung (8.08%). According to the primary site of cancer, breast cancer showed the longest median survival duration (130.93 months), followed by thyroid, kidney, colorectum, bladder, stomach, liver, and lung cancer. On multivariate analyses, overall survival was affected by age and diabetes. Conclusions: The cancer incidence of chronic hemodialysis patients was relatively high. Thus, careful monitoring and a specific cancer screening program are needed for chronic hemodialysis patients.
참고문헌 (14)
- Eggers PW, "Has the incidence of end-stage renal disease in the USA and other countries stabilized", Curr Opin Nephrol Hypertens, 20, pp.241~245 (2011)
- 진동찬, "Lessons from 30 years’ data of Korean end-stage renal disease registry, 1985–2015", Kidney Research and Clinical Practice, 34(3), pp.132~139 (2015), 대한신장학회
- 이정은, "Cancer in Patients on Chronic Dialysis in Korea", Journal of Korean Medical Science, 24, pp.95~101 (2009), 대한의학회
- Yoo KD, "Cancer in Korean patients with end-stage renal disease : a 7-year follow-up", PLoS One, 12, pp.e0178649~ (2017)
- Seong SC, "Data resource profile : the National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- Sundararajan V, "New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality", J Clin Epidemiol, 57, pp.1288~1294 (2004)
- Maisonneuve P, "Cancer in patients on dialysis for end-stage renal disease : an international collaborative study", Lancet, 354, pp.93~99 (1999)
- Butler AM, "Cancer incidence among US medicare ESRD patients receiving hemodialysis, 1996-2009", Am J Kidney Dis, 65, pp.763~772 (2015)
- Chien CC, "Epidemiology of cancer in end-stage renal disease dialysis patients : a national cohort study in Taiwan", J Cancer, 8, pp.9~18 (2017)
- Lin MY, "Association of dialysis with the risks of cancers", PLoS One, 10, pp.e0122856~ (2015)
- Lin HF, "Increased risk of cancer in chronic dialysis patients : a population-based cohort study in Taiwan", Nephrol Dial Transplant, 27, pp.1585~1590 (2012)
- Vamvakas S, "Cancer in end-stage renal disease : potential factors involved editorial", Am J Nephrol, 18, pp.89~95 (1998)
- Shebl FM, "Cancer risk among elderly persons with end-stage renal disease : a population-based case-control study", BMC Nephrol, 13, pp.65~ (2012)
- Birkeland SA, "Cancer risk in patients on dialysis and after renal transplantation", Lancet, 355, pp.1886~1887 (2000)